EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous 
Evolva announces new Chief Financial Officer 
24-March-2021 / 07:00 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 KR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Reinach, March 24, 2021 - Evolva (SIX:EVE) announced today that Carsten Däweritz has been appointed Chief Financial 
Officer. He will report to Oliver Walker, CEO of Evolva, and will join the Management Team of the company effective 
April 16, 2021. 
Oliver Walker, CEO of Evolva, said: «I'm pleased that Carsten has accepted the role of CFO at Evolva. Carsten has 
extensive leadership experience in financial positions. He has our full support and confidence as we continue to grow 
the business.» 
Regarding his appointment, Carsten said: «I'm honored and excited to be given the opportunity to join one of the 
promising biotech businesses.» 
Carsten Däweritz has broad financial experience in the pharma and biotech industry. Before joining Evolva, Carsten 
spent almost 20 years at Lonza in a variety of financial leadership positions. Most recently, he was Global Head 
Controlling of the Consumer Health & Nutrition Business at Lonza. 
Carsten is a Swiss and German citizen. He has a Bachelor in Mathematics and holds a Master in Business Administration 
from the University of Münster, Germany. 
About Evolva 
Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on 
nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's 
employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing 
and sensory enjoyment. Find out more at www.evolva.com. 
For Evolva multi media content, please visit: https://evolva.com/multimedia-library/. 
Disclaimer 
This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, 
expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties 
and other factors which may result in a substantial divergence between the actual results, financial situation, 
development or performance of the company and those explicitly or implicitly presumed in these statements. Against the 
background of these uncertainties readers should not place undue reliance on forward-looking statements. The company 
assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. 
Contact 
Barbara Duci 
Head of Investor and Corporate Relations 
+41 61 485 2003 
+41 79 739 2636 
barbarad@evolva.com 
=---------------------------------------------------------------------------------------------------------------------- 
End of ad hoc announcement 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Evolva Holding SA 
              Duggingerstrasse 23 
              4153 Reinach 
              Switzerland 
Phone:        +41 61 485 20 00 
Internet:     www.evolva.com 
ISIN:         CH0021218067 
Valor:        2121806 
Listed:       SIX Swiss Exchange 
EQS News ID:  1177806 
 
End of Announcement EQS Group News Service 
=------------

1177806 24-March-2021 CET/CEST

(END) Dow Jones Newswires

March 24, 2021 02:03 ET (06:03 GMT)